<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> characterized by peripheral cytopenia and dysplastic bone marrow that arise from mutations in the hematopoietic stem/progenitor cells (HSPC) </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, significant effects have been made to develop appropriate mouse models to study this complex disease </plain></SENT>
<SENT sid="2" pm="."><plain>Three general approaches have been used to establish the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> mouse, including treatment with <z:chebi fb="1" ids="25435">mutagens</z:chebi> or <z:chebi fb="0" ids="50903">carcinogene</z:chebi>, xenotransplantation of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells, and genetic engineering of mouse hematopoietic cells </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, several <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> mouse models and the advances of study on the mechanisms of malignant clone and the marrow microenvironment are summarized </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the progress in xenotransplantation models of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the problems to be solved are discussed briefly </plain></SENT>
</text></document>